Cited by 57Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyAmyotrophic Lateral Sclerosis Research

TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy

Open access
Alquezar, Carolina, Schoch, Kathleen M., Geier, Ethan G., Ramos, Eliana Marisa, Scrivo, Aurora, Li, Kathy H., Argouarch, Andrea R., Mlynarski, Elisabeth E. +10 more·2021·Science Advances

Abstract

TSC1/hamartin haploinsufficiency increases risk for tauopathy by promoting tau acetylation and accumulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.abg3897

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TSC1 haploinsufficiency induced tau acetylation at K343 and 6 other sites without affecting tau phosphorylation.

    “In recent model-based studies, TSC1 haploinsufficiency induced tau acetylation (at K343 and 6 other sites) without affecting tau phosphorylation [2].”

    From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [2]

    The Results section (‘Tau from TSC1+/− cells undergoes aberrant acetylation that affects its degradation’; page not provided) reports no increase in tau phosphorylation and identifies six uniquely acetylated sites in TSC1+/− cells, including K343—not K343 plus six others. A seventh site, K174, was acetylated in both control and TSC1+/− cells. (LLM, conf=0.92)

    Experimental — accuracy not yet measured
  • TSC1 haploinsufficiency led to specific tau acetylation (at K343 and other sites) and tau accumulation, mediated by dysregulation of p300 acetyltransferase and SIRT1 deacetylase.

    “our recent study [2] suggested that TSC1 haploinsufficiency led to specific tau acetylation (at K343 and other sites) and tau accumulation, mediated by dysregulation of p300 acetyltransferase and SIRT1 deacetylase.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [11]D. M. Hasbani, P. B. Crino, in Handbook of Clinical Neurology (Elsevier B.V., 2018), vol. 148, pp. 813–822. 29478616

Cited by

Sorted by citations

Authors
Alquezar, C., Schoch, K. M., Geier, E. G., Ramos, E. M., Scrivo, A., Li, K. H., Argouarch, A. R., Mlynarski, E. E., Dombroski, B., DeTure, M., Dickson, D. W., Yokoyama, J. S., Cuervo, A. M., Burlingame, A. L., Schellenberg, G. D., Miller, T. M., Miller, B. L., & Kao, A. W.
Affiliations
  • University of California, San Francisco (US)
  • Washington University in St. Louis (US)
  • University of California, Los Angeles (US)
  • Albert Einstein College of Medicine (US)
  • University of Pennsylvania (US)
  • Mayo Clinic in Florida (US)
Corresponding author
Kao, Aimee W.
Venue
Science Advances
Published
2021-11-05
Volume
7
Issue
45
Pages
eabg3897-eabg3897
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3210060307
Cited by
56
References
66
Citations by year
2026: 14 · 2025: 6 · 2024: 11 · 2023: 17 · 2022: 8
FWCI
5.80
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
Funders
National Institute on Aging (P01AG031782, P01AG019724)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
TSC1, tauopathy, tau acetylation, chaperone-mediated autophagy, haploinsufficiency, tau clearance, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review